World's Best Scientists 2026 revealed!
Pierre-François Plouin

Pierre-François Plouin

D-Index & Metrics

Medicine

D-Index
90
Citations
30280
World Ranking
12194
National Ranking
381

Pierre-François Plouin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pierre-François Plouin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 414 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pierre-François Plouin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pierre-François Plouin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pierre-François Plouin is affiliated with Université Paris Cité in France. Their research spans the fields of Medicine and Neuroscience, with a focus on subfields such as Neurology, Surgery, Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism, and Cardiology and Cardiovascular Medicine.

The scientist's work addresses a range of topics connected to neurological and cardiovascular health. Key topics include:

  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Hormonal Regulation and Hypertension
  • Cardiovascular Syncope and Autonomic Disorders
  • Nuclear Receptors and Signaling
  • Adrenal and Paraganglionic Tumors
  • Blood Pressure and Hypertension Studies

Notable recent publications by Pierre-François Plouin feature diverse studies in medical research:

  • Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial (2022, The Lancet)
  • Parkinson's disease outside the brain: targeting the autonomic nervous system (2021, The Lancet Neurology)
  • The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients (2020, Cardiovascular Research)
  • Cardiac noradrenergic deficiency revealed by 18F-dopamine positron emission tomography identifies preclinical central Lewy body diseases (2023, Journal of Clinical Investigation)
  • Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies (2021, Journal of Neurochemistry)

The scientist has collaborated frequently with colleagues such as Avshalom Leibowitz, David S. Goldstein, Ehud Grossman, Patti Sullivan, and Tiran Golani.

Publications by Pierre-François Plouin appear mostly in journals including:

  • Clinical Autonomic Research
  • Journal of Hypertension
  • The Lancet
  • The Lancet Neurology
  • Cardiovascular Research

Best Publications

  • Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

    Paul Milliez;Xavier Girerd;Pierre-François Plouin;Jacques Blacher

  • Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis and Impaired Renal Function: A Randomized Trial

    Liesbeth Bax;Arend-Jan J. Woittiez;Hans J. Kouwenberg;Willem P. T. M. Mali

  • Blood Pressure Outcome of Angioplasty in Atherosclerotic Renal Artery Stenosis: A Randomized Trial

    Pierre François Plouin;Gilles Chatellier;Bernadette Darné;Alain Raynaud

  • Genetic Testing in Pheochromocytoma or Functional Paraganglioma

    Laurence Amar;Jérôme Bertherat;Eric Baudin;Christiane Ajzenberg

  • Clinical presentation and penetrance of Pheochromocytoma/ Paraganglioma syndromes.

    Diana E. Benn;Anne Paule Gimenez-Roqueplo;Jennifer R. Reilly;Jérôme Bertherat

  • Mutations in the SDHB Gene Are Associated with Extra-adrenal and/or Malignant Phaeochromocytomas

    Anne-Paule Gimenez-Roqueplo;Judith Favier;Pierre Rustin;Claudine Rieubland

  • Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial

    Michel Azizi;Michel Azizi;Marc Sapoval;Marc Sapoval;Philippe Gosse;Matthieu Monge

  • An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism.

    Gian Paolo Rossi;Richard J. Auchus;Morris Brown;Jacques W.M. Lenders;Jacques W.M. Lenders

  • Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.

    Felix Beuschlein;Sheerazed Boulkroun;Sheerazed Boulkroun;Andrea Osswald;Thomas Wieland

  • Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study

    Sébastien Savard;Laurence Amar;Pierre-François Plouin;Olivier Steichen

  • The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.

    Anne-Paule Gimenez-Roqueplo;Judith Favier;Pierre Rustin;Jean-Jacques Mourad

  • Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas

    Laurence Amar;Eric Baudin;Nelly Burnichon;Séverine Peyrard

  • European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma

    P F Plouin;L Amar;O M Dekkers;M Fassnacht

  • First International Consensus on the diagnosis and management of fibromuscular dysplasia.

    Heather L. Gornik;Alexandre Persu;David Adlam;Lucas S. Aparicio

  • Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma.

    Laurence Amar;Aude Servais;Anne Paule Gimenez-Roqueplo;Franck Zinzindohoue

  • The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.

    Nelly Burnichon;Nelly Burnichon;Vincent Rohmer;Laurence Amar;Laurence Amar;Philippe Herman

  • Masked hypertension: a systematic review.

    Guillaume Bobrie;Pierre Clerson;Joël Ménard;Nicolas Postel-Vinay

  • The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.

    Gian Paolo Rossi;Marlena Barisa;Bruno Allolio;Richard J. Auchus

  • MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

    Nelly Burnichon;Alberto Cascón;Francesca Schiavi;Nicole Paes Morales

  • Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.

    Christine Gicquel;Xavier Bertagna;Véronique Gaston;Joël Coste

Frequent Co-Authors

Xavier Jeunemaitre
Xavier Jeunemaitre Université Paris Cité
Pierre Corvol
Pierre Corvol Collège de France
Gilles Chatellier
Gilles Chatellier Université Paris Cité
Anne-Paule Gimenez-Roqueplo
Anne-Paule Gimenez-Roqueplo Université Paris Cité
Jérôme Bertherat
Jérôme Bertherat Université Paris Cité
Stéphane Laurent
Stéphane Laurent Université Paris Cité
Xavier Bertagna
Xavier Bertagna Université Paris Cité
Eric Baudin
Eric Baudin Institut Gustave Roussy

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t have to follow a traditional path. There are diverse online degree options for students interested in healthcare roles beyond the MD. For those passionate about nutrition, an online dietitian degree offers flexibility while preparing you for roles in dietetics and nutrition counseling.

If you’re interested in healthcare leadership or policy, consider accredited mha programs online. These programs, designed for future healthcare administrators, allow you to specialize in management without stepping away from your current career.

For registered nurses aiming to advance, there are online rn to bsn programs without clinicals that streamline the process and eliminate on-site clinical hours, making upskilling more accessible.

Advanced practice nurses might be interested in accelerated dnp programs, which condense coursework for quicker entry into high-level clinical and leadership roles.

These online pathways can help you enter or advance in healthcare—with the convenience of remote study and the flexibility to fit your schedule.

Best Scientists Citing Pierre-François Plouin

Trending Scientists

Recently Published Articles